Welcome! You are visiting the MyeloRx web site.

Home
About Us
Contact Us
Site Map
Lead Compounds
Clinical Efficacy - Leuke
Natural Products
Our Strategy
Intellectual Property
Targets
Acute Myeloid Leukemia
Lead Compound - MRx102
MRx102
AML Xenograft Model (MV4-
Pilot Toxicity
Summary
Intellectual Property
 
 TitleFiling DateStatus

Lead

Compound

Lactone Ring

Compounds

2004 Pending (US) MRx102

Halogenated

Compounds

2004 Granted (US)  MRx103 

C Ring

Compounds

2008  Pending (US) MRx104 

Rigid

Compounds

 2007 Pending (US) 

MRx105

MRx106